A

ADC Therapeutics SA
D

ADCT

1.98500
USD
0.04
(2.06%)
Market Closed
Volume
11,932
EPS
-2
Div Yield
-
P/E
-1
Market Cap
191,928,890
OverviewSignalsIdeasNews
Related Instruments
    C
    CIEN
    -2.550
    (-3.66%)
    67.210 USD
    CSCO
    CSCO
    -0.440
    (-0.76%)
    58.56 USD
    DELL
    DELL
    -2.820
    (-2.10%)
    131.620 USD
    H
    HPE
    -0.270
    (-1.27%)
    21.070 USD
    HPQ
    HPQ
    0.240
    (0.66%)
    36.730 USD
    IBM
    IBM
    -4.040
    (-1.93%)
    223.04 USD
    I
    INFN
    -0.01000
    (-0.15%)
    6.64000 USD
    INTC
    INTC
    -0.695
    (-2.78%)
    24.495 USD
    J
    JNPR
    -1.925
    (-5.01%)
    36.495 USD
    NTAP
    NTAP
    -0.860
    (-0.73%)
    117.210 USD
    More
News

Title: ADC Therapeutics SA

Sector: Healthcare
Industry: Biotechnology
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.